ASCRS logo 3

APRIL 16, 2015 | SAN DIEGO, CA

Agenda

7:30 - 8:30 am General Attendance Check-in & Networking Breakfast
Hosted By:
Genentech
8:30 - 8:35 am Welcome & Opening Remarks
OIS Co-Chair:
William J. Link, PhD, Managing Director - Versant Ventures
8:35 - 9:15 am 2015 Review of the Ophthalmology Innovation Cycle
Innovation Cycle Overview & Financing Environment Update
William J. Link, PhD, Managing Director - Versant Ventures

Panel Discussion
Moderated By:
William J. Link, PhD, Managing Director - Versant Ventures

Panel Participants:
Richard L. Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants
Joe Gilliam, Managing Director, Healthcare Investment Banking – J.P. Morgan
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner - Clarus Ventures
Buzz Benson, Managing Director - SightLine Partners

9:15 - 10:15 am Ophthalmic Companies Showcase
Co-Moderated By:
Tracy Valorie, Sr. VP & General Manager Pharmaceuticals Division – Bausch + Lomb
Rose Wynne Brooks, Vice President Marketing – Carl Zeiss Meditec AG

9:15-9:20 – Eleven Biotherapeutics – Abbie C. Celniker, PhD, President & CEO
9:20-9:25 – Avedro – David Muller, PhD, President & CEO
9:25-9:30 – AcuFocus – Nick Tarantino, Chief Global Clinical Research & Regulatory Affairs Officer
9:30-9:35 – ReVision Optics – John T. Kilcoyne, President & CEO
9:35-9:40 – PowerVision – Barry Cheskin, President, CEO & Co-Founder
9:40-9:45 – Emmetrope – Andrew F. Phillips, MD, Founder, President & CEO
9:45-9:50 – Sharklet Technologies – Mark Spiecker, CEO
9:50-9:55 – ClearSight Innovations – Michael Mrochen, PhD, Co-Founder & CTO
9:55-10:00 – Mynosys - John Hendrick, President & CEO
10:00-10:05 – Jade Therapeutics - Arthur Klausner, MBA, CEO
10:05-10:10 – MicroOptx - Chris Pulling, CEO
10:10-10:15 – LacriScience - Chris Geddes, PhD, Chief Biomedical/Plasmonics Consultant

10:15 - 10:45 am Networking Break
10:45 - 11:25 am Spotlight on MIGS
Market Overview
Eric D. Donnenfeld, MD, Clinical Professor, Ophthalmology - NYU

Company Presentations
Glaukos - Chris M. Calcaterra, Chief Commercial Officer
Ivantis - Dave Van Meter, President & CEO
Transcend Medical - Sean Ianchulev, MD, MPH, Chief Medical Officer & Vice President, Business Development
AqueSys - Ron Bache, President & CEO

Panel Discussion
Moderated By:
Eric D. Donnenfeld, MD, Clinical Professor, Ophthalmology - NYU

Panel Participants:
Richard A. Lewis, MD, Sacramento Eye Consultants
Kerry Solomon, MD, Partner - Carolina Eyecare Physicians
Mark Rosenberg, MD, CEO - Barnet Dulaney Perkins Eye Center

11:25am - 12:05 pm Spotlight on Pressure Reduction
Market Overview
Kuldev Singh, MD, MPH, Professor, Ophthalmology & Director, Glaucoma Service - Stanford University School of Medicine

Company Presentations
Aerie Pharmaceuticals - Thomas A. Mitro, President & COO
InnFocus - Russ Trenary, President & CEO
ForSight VISION5 - John Maroney, CEO

Panel Discussion
Moderated By:
Kuldev Singh, MD, MPH, Professor, Ophthalmology & Director, Glaucoma Service - Stanford University School of Medicine

Panel Participants:
Thomas A. Mitro, President & COO - Aerie Pharmaceuticals
Russ Trenary, President & CEO - InnFocus
John Maroney, CEO - ForSight VISION5
John Berdahl, MD, Ophthalmologist - Vance Thompson Vision
Jay Katz, MD, Director, Glaucoma Service - Wills Eye Hospital

12:05 pm Networking Lunch Commences
Hosted By:
Abbott Medical Optics
12:40 - 12:45 pm Special Introduction
Special Introduction By:
Calvin W. Roberts, MD, Sr. VP & Chief Medical Officer, Eye Care - Bausch + Lomb
12:45 - 1:05 pm Plenary Talk: Valeant's Approach to Innovation
J. Michael Pearson, Chairman of the Board & CEO - Valeant Pharmaceuticals
1:05 - 1:30 pm Ophthalmology Lifetime Innovator Award
1:30 pm Networking Lunch Concludes
1:30 - 2:10 pm Spotlight on Presbyopia: New Technology IOLs
Market Overview
Richard L. Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants

Panel Discussion
Moderated By:
Gilbert H. Kliman, MD, Managing Director - InterWest Partners

Panel Participants:
Malvina B. Eydelman, MD, Director, Division of Ophthalmic and Ear, Nose & Throat Devices - FDA
Jack T. Holladay, MD, MSEE, FACS, Clincal Professor of Ophthalmology - Baylor College of Medicine
Calvin W. Roberts, MD, Sr. VP & Chief Medical Officer, Eye Care - Bausch + Lomb
Laurent Attias, Head, Strategy, BD&L & Market Access - Alcon
Jane E. Rady, Divisional Vice President, Business Development - Abbott Medical Optics

2:10 - 2:50 pm Spotlight on Drug Delivery
Company Presentations
Envisia Therapeutics - Benjamin Yerxa, PhD, President & Co-Founder
Kala Pharmaceuticals - Charlie McDermott, Interim President & Chief Business Officer
Icon Bioscience - David S. Tierney, President & CEO
Ocular Therapeutix - Amarpreet Sawhney, PhD, President, CEO & Chairman of the Board

Panel Discussion
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner - Clarus Ventures
K. Angela Macfarlane, President & CEO - ForSight Labs

Panel Participants:
Amarpreet Sawhney, PhD, President, CEO & Chairman - Ocular Therapeutix
Charlie McDermott, Interim President & Chief Business Officer - Kala Pharmaceuticals
David S. Tierney, President & CEO - Icon Bioscience
Benjamin Yerxa, PhD, President & Co-Founer - Envisia Therapeutics
Kristin J. Havranek, Associate - Wilson Sonsini Goodrich & Rosati

2:50 - 3:20 pm Networking Break
3:20 - 4:00 pm Alternative Financing Approaches
Moderated By:
Tom Salemi, Content Director - Healthegy

Panel Participants:
William J. Link, PhD, Managing Director - Versant Ventures
Matthew Chapin, Sr. VP, Corporate Development - Ora
Andy Corley, Founder - Yelroc Consulting

4:00 - 4:40 pm Masters of the Universe
Moderated By:
James V. Mazzo, Chairman & CEO - AcuFocus, Executive Chairman - Neurotech

Panel Participants:
Jeff George, Global Head - Alcon
William J. Link, PhD, Managing Director - Versant Ventures
J. Michael Pearson, Chairman of the Board & CEO - Valeant Pharmaceuticals
Murthy V. Simhambhatla, PhD, Sr. VP - Abbott Medical Optics
Ludwin Monz, President & CEO - Carl Zeiss Meditec AG

4:40 - 5:00 pm Closing Remarks
5:00 - 6:30 pm Networking Reception
Hosted By:
Alcon